Related Experiment Video
Updated: Dec 30, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Thromboelastography-targeted management of severe coagulopathy and off-label use of four-factor prothrombin complex
Proshad N Efune1, Gijo Alex1, Janna Journeycake2
1Department of Anesthesia and Pain Management.
Insights
A severe enteroviral infection led to a critical bleeding event in an infant. Thromboelastography-guided transfusions effectively controlled the massive hemorrhage, proving invaluable for patient management.
Area of Science:
- Pediatric critical care medicine
- Hematology
- Infectious diseases
Background:
- A 4-month-old infant presented with multiorgan failure and cerebellar hemorrhage due to disseminated enteroviral infection.
- The patient required listing for liver transplant due to the severity of the illness.
Observation:
- Severe coagulopathy developed, leading to a hemothorax after central line placement.
- Massive bleeding persisted despite surgical intervention and recombinant factor VIIa administration.
Findings:
- Bleeding was successfully controlled using thromboelastography-guided transfusion of platelets and cryoprecipitate.
- Administration of four-factor prothrombin complex concentrate was also crucial in achieving hemostasis.
Implications:
- This case highlights the effectiveness of a thromboelastography-guided transfusion strategy in managing severe, iatrogenic bleeding in critically ill infants.
- The findings underscore the importance of advanced coagulation monitoring and targeted therapy in pediatric critical care.
Abstract:
: A 4-month-old girl initially presented to the pediatric ICU at 9 days old with multiorgan failure and cerebellar hemorrhage secondary to disseminated enteroviral infection and was eventually listed for liver transplant. Due to severe coagulopathy, she developed a hemothorax after line placement. Despite operative exploration and multiple recombinant factor VIIa doses, massive bleeding continued. The bleeding was finally controlled with thromboelastography-targeted platelet and cryoprecipitate transfusion in addition to four-factor prothrombin complex concentrate administration. This management strategy was invaluable in controlling bleeding from an iatrogenic cause.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

